Cel AI PLC (LON:CLAI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.6850
+0.0950 (16.10%)
Jun 20, 2025, 5:10 PM BST
341.94%
Market Cap 5.92M
Revenue (ttm) 1.00
Net Income (ttm) -1.35M
Shares Out 863.53M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 110,856,203
Average Volume 104,181,357
Open 0.5888
Previous Close 0.5900
Day's Range 0.5600 - 0.7500
52-Week Range 0.0300 - 0.9400
Beta 0.47
RSI 59.82
Earnings Date Jun 3, 2025

About Cel AI

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare products. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom. [Read more]

Founded 2018
Employees 1
Stock Exchange London Stock Exchange
Ticker Symbol CLAI
Full Company Profile

Financial Performance

In 2024, Cel AI's revenue was 17,942, a decrease of -73.31% compared to the previous year's 67,236. Losses were -1.83 million, -44.79% less than in 2023.

Financial Statements

News

There is no news available yet.